Is the cardiovascular system a therapeutic target for cannabidiol?
Subject: Heart Disease - PUBLISHED VIA British Pharmacological Society
Author(s): View Source >>
Stanley CP, Hind WH, O'Sullivan SE
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Published via Author Manuscript
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Published via American Journal of Physiology
Published via BMJ Publishing Group Limited
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.
Published via Journal of Cardiovascular Pharmacology and Therapeutics
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Published via British Journal of Pharmacology